Cochrane Abstracts
Fluticasone versus 'extrafine' HFA‐beclomethasone dipropionate for chronic asthma in adults and children
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fluticasone Versus 'extrafine' HFA‐beclomethasone Dipropionate for Chronic Asthma in Adults and Children." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435653/all/Fluticasone_versus_&apos.
Fluticasone versus 'extrafine' HFA‐beclomethasone dipropionate for chronic asthma in adults and children. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435653/all/Fluticasone_versus_&apos. Accessed February 8, 2026.
Fluticasone versus 'extrafine' HFA‐beclomethasone dipropionate for chronic asthma in adults and children. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435653/all/Fluticasone_versus_&apos
Fluticasone Versus 'extrafine' HFA‐beclomethasone Dipropionate for Chronic Asthma in Adults and Children [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435653/all/Fluticasone_versus_&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fluticasone versus 'extrafine' HFA‐beclomethasone dipropionate for chronic asthma in adults and children
ID - 435653
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435653/all/Fluticasone_versus_&apos
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
